Bank of America expects three Fed hikes this year, says inflation is getting 'unambiguously worse'
Original Report
The bank's economists reversed their position held as recently as last week that the central bank would stay on hold this year.
Glass House Analysis
This development in the banking sector reflects broader tensions between regulatory pressure and financial industry practices. The banking system serves as the circulatory system of the economy; any disruption ripples through to small businesses, homebuyers, and everyday consumers who depend on credit access.
Central bank policy decisions made in boardrooms cascade through the economy in ways that touch everyone. A quarter-point rate change might seem abstract, but it determines whether young families can afford homes, whether businesses can afford to hire, and whether retirees see meaningful returns on their savings. The tension between fighting inflation and maintaining employment represents a fundamental tradeoff in economic policy—one that invariably creates winners and losers.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
S&P 500 runs out of steam, falls into the red as Big Tech, SpaceX struggle: Live updates
The S&P 500 was relatively unchanged on Monday, while oil prices fell, as Wall Street assessed the latest developments in the Iran war negotiations.
The loneliness crisis has gotten so bad that lawmakers are ready to spend millions of dollars to fight it
The health damage of loneliness is similar to heavy smoking and obesity
Psychedelic Drugmaker Definium Surges on Depression Drug Success
Definium Therapeutics Inc. shares rally as much as 60% Monday after late-stage trial data showed “groundbreaking” results in the psychedelic drug developer’s experimental treatment for major...